Voronoi, Inc. (KOSDAQ:310210)
193,500
-13,500 (-6.52%)
Jun 12, 2026, 3:30 PM KST
Voronoi Revenue
Voronoi had revenue of 7.51B KRW in the twelve months ending March 31, 2026. In the year 2025, Voronoi had annual revenue of 7.51B.
Revenue
7.51B
Revenue Growth
n/a
P/S Ratio
463.61
Revenue / Employee
53.66M
Employees
140
Market Cap
3.48T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.51B | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.77B | -5.02B | -33.93% |
| Dec 31, 2021 | 14.78B | 8.60B | 139.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SK Biopharmaceuticals | 790.25B |
| SK bioscience | 665.42B |
| PharmaResearch | 565.48B |
| Hugel | 451.93B |
| LigaChem Biosciences | 125.87B |
| HLB Co., Ltd. | 85.20B |
| OliX Pharmaceuticals | 17.26B |
| Peptron | 5.98B |